Jim Mastakas, Senior Vice President and Chief Financial Officer, Virtus Pharmaceuticals
Jim joined Amneal as Senior Vice President and Chief Financial Officer in March 2015, where he is responsible for all global accounting and finance functions, including financing activities, strategic planning, KPI’s , budgeting and forecasting and business support. He was instrumental in closing a deal with Impax valued at approximately $7 billion in May 2018. Prior to Amneal served as Senior Vice President and Chief Financial Officer for CorePharma and Tower Holdings, Inc. where he helped to successfully sell the company for $700 million.
Prior to CorePharma, Jim was CFO of Eagle Pharmaceuticals and CFO for North American at Sandoz, the generic arm of Novartis. In addition, Jim held various leadership positions in finance and corporate accounting at Mylan Pharmaceuticals, Wyeth Pharmaceuticals and Ernst & Young.
Jim has 21 years of experience in the pharmaceuticals industry including 15 in the generics sector. Holds B.S. degree in accounting from Bentley University and has a CPA certification.
Array (  => Alissa Cadigan - RSM US  => Anthony DeGraw - Domain Domain Services  => Ashley Sarohkian - Capital One  => Ashwin Rao - Collabera  => Badri Nittoor - eureQa  => Benjamin Novak - Morgan Lewis  => Bin Guan - Yorktel  => Blake Goodman - JLL  => Blake Roberts - BDO  => Bret Morgan - CoWerking  => Christina Giglio - Robert Half  => Edward O'Connell - Withum  => George Abraham - Rhodium Strategies  => Hitesh Ramani - Deloitte  => Jennifer Lee - Edison Partners  => John Genovese - Pivotal Labs  => Joshua Goldberg - Nath, Goldberg and Meyer  => Kevin Askew - TechXtend  => Kevin Richards - Princeton Identity  => Leah Dell'Aquila - Mission50  => Marc McCabe - Crystal & Company  => Matt De Jesus - Flexential  => Michael Dietze - TierPoint  => Michael Galkin - VoiceNext  => Michelle Capezza - Epstein Becker & Green  => Mike Funk - TenFour  => Mike Profit - WorkWave  => Moreen Beshara - EY  => Parag Pruthi - Niksun  => Pavita Howe - Rutgers University  => Phil Antoon - Alvarez & Marsal  => Phil Kennard - Futurestay  => Phil Romero - Grant Thornton  => Richard Cleaveland - Eisner Amper  => Scott Cowan - DLA Piper  => Steven Malen - Integrative Care Alliance  => Tim Dluoik - KPMG  => Timur Pakay - FDU  => Tor Alden - HS Design  => Vijay Ajuwalia - Edward Jones )